HSP 58.01 Hospira Inc $HSP Hit a 52 week high of 58.25

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
HSP 58.01 Hospira Inc $HSP Hit a 52 week high of 58.25 Closing the day 09:45 at 58.01 -0.08 -0.14% With a day low of 58.15 and a total volume of 12,371.

HSP Recent Posts: http://investorshangout.com/Hospira-Inc-HSP-51354/

HSP Hospira Inc Recent Headline News

Earnings Triple Plays
Bespoke Investment Group - Seeking Alpha - Wed Nov 12, 1:54AM CST
The third quarter earnings season unofficially comes to an end on Thursday when Wal-Mart (NYSE: WMT ) reports earnings before the open. So far this earnings season, more than 2,000 companies have reported their quarterly numbers, and our job here is...
GD: 143.11 (+1.81), ACT: 242.81 (+2.19), CBG: 32.65 (-0.06), HCP: 43.73 (+0.43), BCR: 165.94 (+0.73), PCG: 49.93 (-0.21), AMGN: 160.03 (-1.90), CB: 101.67 (+0.15), SRE: 110.13 (-0.52), PLD: 41.12 (+0.12), HSP: 57.91 (-0.18), TWX: 79.00 (+1.32), KIM: 24.81 (+0.21), CMI: 144.62 (-1.87), ALXN: 191.87 (-1.82), ESS: 201.29 (+0.85), ABBV: 63.94 (+0.18), CAT: 101.59 (-1.40), AAPL: 113.11 (+1.86)

Amgen's brodalumab beats Stelara in Phase 3 trial
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 3:52PM CST

CANF: 2.70 (+0.16), JNJ: 108.95 (+0.20), IDRA: 2.48 (-0.08), DERM: 16.00 (-0.25), MRK: 59.72 (+0.41), PFE: 30.47 (+0.05), AZN: 74.63 (+0.37), AMGN: 160.03 (-1.90), GSK: 45.71 (+0.09), HSP: 57.91 (-0.18), NVS: 94.52 (+1.86), CELG: 107.16 (-1.09)

Hospira Inc.'s Third-Quarter Earnings: The 3 Key Takeaways
Leo Sun, The Motley Fool - Motley Fool - Fri Nov 07, 10:53AM CST
Shares of Hospira jumped nearly 7% on Nov. 6 after the maker of injectable drugs and infusion technologies reported impressive third-quarter earnings. Source: Wikimedia Commons. Hospira's revenue climbed 2% year over year to $1.2 billion,...
HSP: 57.91 (-0.18)

Stock Market News for November 07, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 9:10AM CST
Benchmarks ended in the green zone yesterday following ECB President Mario Draghi’s statement regarding possible expansion of monetary stimulus by the European Central Bank
DHI: 24.27 (+0.26), WFM: 46.45 (-1.03), TSLA: 252.94 (+3.84), LEN: 45.55 (-0.01), QCOM: 70.55 (+0.26), PHM: 20.77 (+0.08), TOL: 33.67 (+0.16), GNW: 9.22 (+0.42), HSP: 57.91 (-0.18)

Strength Seen in Hospira (HSP): Stock Moves 6.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:25AM CST
Hospira (HSP) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 83.95 (-0.78), ABAX: 55.10 (+0.90), GWPH: 75.46 (+0.14), HSP: 57.91 (-0.18)

Look for Shares of Hospira to Potentially Pullback after Yesterday's 6.67% Rise
Comtex SmarTrend(R) - Thu Nov 06, 4:13PM CST
Hospira (NYSE:HSP) traded in a range yesterday that spanned from a low of $55.00 to a high of $58.00. Yesterday, the shares gained 6.7%, which took the trading range above the 3-day high of $53.88 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HSP: 57.91 (-0.18)

Watch for Hospira to Potentially Pullback After Gaining 6.67% Yesterday
Comtex SmarTrend(R) - Thu Nov 06, 4:13PM CST
Hospira (NYSE:HSP) traded in a range yesterday that spanned from a low of $55.00 to a high of $58.00. Yesterday, the shares gained 6.7%, which took the trading range above the 3-day high of $53.88 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HSP: 57.91 (-0.18)

Hospira Beats on Earnings & Sales in Q3, Narrows Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:53PM CST
Hospira reported third-quarter 2014 adjusted earnings of 74 cents per share.
AGN: 196.39 (-0.12), ABAX: 55.10 (+0.90), ABBV: 63.94 (+0.18), HSP: 57.91 (-0.18)

Hospira (HSP) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Thu Nov 06, 12:39PM CST
The following Hospira (HSP) conference call took place on November 6, 2014, 09:00 AM ET. This is a transcript of that earnings call:
HSP: 57.91 (-0.18)

Hospira's (HSP) CEO Michael Ball on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 12:20PM CST

HSP: 57.91 (-0.18)

Hospira Q3 income up big
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 8:11AM CST

HSP: 57.91 (-0.18)

Hospira (HSP) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 06, 7:55AM CST

HSP: 57.91 (-0.18)

Hospira unveils generic Paricalcitol Injection in three multi-dose sizes
M2 - Thu Nov 06, 7:28AM CST
Injectable drug company

Hospira Inc (HSP) Stock Research Links

HSP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Affordable Emergency Housing by ROKiT: A Solution for All

Updated Category News Views 314

Introducing ROKiT Industries' Affordable Housing Initiative ROKiT Industries is stepping forward with an innovative solution aimed at addressing homelessness and displacement. The company presents an emergency housing option that combines quality and affordability, available for as little as $5 a week. This initiative is designed to support communities facing challenges...

Continue Reading
Innovative Electric Road Charging System Charts Sustainable Future

Updated Category News Views 170

Revolutionizing Electric Vehicle Technology BEIT YANAI, Israel, has become a focal point for innovative vehicle charging solutions. On the A10 motorway, a project integrating electric heavy-duty vehicle charging while in motion is underway. The initiative is spearheaded by VINCI Autoroutes in collaboration with Electreon, VINCI Construction, Gustave Eiffel University, and...

Continue Reading
Examining Fairness: The Overview of IAS Transaction Dealings

Updated Category News Views 143

Understanding the Investigation of Integral Ad Science The Ademi Firm is actively investigating Integral Ad Science (NASDAQ: IAS) regarding the execution of its recent transaction with Novacap. This inquiry comes amid concerns of potential breaches in fiduciary duties and various legal violations that could affect shareholders. Transaction Overview and Shareholder...

Continue Reading
Leadership Expansion at Diversified Energy Company PLC

Updated Category News Views 249

Recent Announcements from the Board of Directors Diversified Energy Company PLC ("Diversified" or "the Company") is thrilled to share important news regarding its Board of Directors. The latest decision sees the appointment of Randall Wade as an independent non-executive director, a strategic move that took place on 11 April 2025. Meet Randall Wade: A Seasoned Industry...

Continue Reading
Andy Knapp Brings Extensive Expertise to Anderson & Vreeland

Updated Category News Views 151

Andy Knapp Enhances Team at Anderson & Vreeland Anderson & Vreeland Inc., a key player in the flexographic printing sector, is pleased to announce the addition of Andy Knapp to its team as a Technical Manager. With more than 15 years of experience in the industry, Knapp will concentrate on advancing photopolymer plate imaging technologies along with flexography,...

Continue Reading